Navigation Links
Symmetry Medical to Present at Canaccord Adams Small-Cap Orthopedics Conference
Date:2/25/2008

WARSAW, Ind., Feb. 25 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), an independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, is scheduled to present at the Canaccord Adams Small-Cap Orthopedics Conference at The Mission Bay Conference Center at UCSF, in San Francisco, CA on Tuesday, March 4, 2008 at 1:50 p.m. PT (4:50 p.m. ET).

A live Web cast of the presentation will be available on Symmetry Medical's Web site at http://www.symmetrymedical.com. Presentation slides will be posted on the Web site before the presentation begins. A replay of the Web cast will be available for 60 days after the date of the presentation.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Investors/Media: Contact:

The Ruth Group Symmetry Medical Inc.

Nick Laudico/Jason Rando Fred L. Hite

(646) 536-7030/7025 Senior Vice President

nlaudico@theruthgroup.com Chief Financial Officer

jrando@theruthgroup.com
'/>"/>

SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Symmetry Medical Reports Preliminary Fourth Quarter Revenue
2. Symmetry Medical Expands Board of Directors
3. Symmetry Medical Reports Preliminary Third Quarter Revenue
4. Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7, 2007
5. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
6. CIGNA Medical Group Selects Allscripts for Electronic Health Record
7. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
8. B-Line Medical and Immersion Medical Announce Partnership
9. MIT researcher addresses biomedical engineering challenges
10. Eklin Medical Reports Record Revenues for 2007
11. Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014   Synthetic Biologics, ... developing novel anti-infective biologic and drug programs targeting ... announced today that its novel C. difficile ... 54 th Interscience Conference on Antimicrobial Agents ... Washington D.C. Synthetic Biologics, ...
(Date:8/18/2014)... -- A new therapy developed by researchers at ... of Medicine and Columbia University Medical Center (CUMC) ... cardiovascular disease treatment. , The researchers demonstrated ... therapy could selectively inhibit blood vessel re-narrowing and ... using a balloon catheter to open narrowed or ...
(Date:8/18/2014)... unprecedented efficiency and data storage may someday ... electric polarizations to read and write digital ... data-driven technology. But ferroelectrics must first overcome ... curious habit of "forgetting" stored data. ... of Energy,s Brookhaven National Laboratory have discovered ...
(Date:8/18/2014)... 2014 TNI BioTech, Inc. (OTC-BB: TNIB) ("we" ... and marketing of innovative therapies for autoimmune diseases in ... a second notice of TNI BioTech,s annual meeting of ... Noreen Griffin , founder and CEO of TNI ... participation in the Annual Meeting. On behalf of our ...
Breaking Biology Technology:Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4
... N.C., Feb. 25 Attagene Inc., a,biotechnology ... analysis, announced today that one of the ... FACTORIAL(TM). In,advance online publication on Nature Methods, ... novel and remarkably consistent method for,simultaneously reporting ...
... 25 t2cure, a clinical,stage biopharmaceutical company developing ... today that it has appointed,Dr. Petra Rueck Head ... have Petra join our company", said Manfred Ruediger,CEO ... project,management will be of critical importance to t2cure ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announced today that ... President of ImClone Systems Incorporated, will,join its Board of ... size of its Board from six to seven directors., ... Board of Directors. He brings,tremendous knowledge and expertise within ...
Cached Biology Technology:Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 2Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 3Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations 2Eric K. Rowinsky Joins ADVENTRX Board of Directors 2Eric K. Rowinsky Joins ADVENTRX Board of Directors 3Eric K. Rowinsky Joins ADVENTRX Board of Directors 4
(Date:8/19/2014)... fish purchased at retail seafood counters in 10 ... can expose consumers to unexpectedly high levels of ... falsely present a fish of the same species, ... dangerous mislabeling offense, according to new research by ... labeling of seafood is essential to allow consumers ...
(Date:8/19/2014)... -- ( Aug. 19, 2014 ) -- Scientists at ... to pick up and transfer single cells using a ... slightly. They describe this engineering feat and preliminary test ... of the American Chemical Society . , "Studying single ... in current biomedical research," said nanomedicine department. faculty member ...
(Date:8/19/2014)... who has ever had a glass of fizzy soda ... air. But in a finding with wide industrial applications, ... some particles down into the liquid as well. , ... droplets, so we were surprised, and fascinated, to discover ... same process injected tiny oil droplets into the water," ...
Breaking Biology News(10 mins):Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Moving single cells around -- accurately and cheaply 2Bubbling down: Discovery suggests surprising uses for common bubbles 2Bubbling down: Discovery suggests surprising uses for common bubbles 3
... Washington DC (February 11, 2010) While many adults consider ... to be obese teens, saddling them with Type-2 diabetes, elevated ... this month in the journal Clinical Pediatrics (published ... point" in obesity often occurs before two years of age, ...
... Sultan, assistant professor of aerospace and ocean engineering at Virginia ... learn he has received a National Science Foundation (NSF) Faculty ... list of more than 70 Virginia Tech CAREER award winners, ... of Engineering since the award was created in 1994. He ...
... modifications to proteins called histones, which are found in ... which DNA is wound, can be used to predict ... pancreatic cancer, a study by researchers at UCLA,s Jonsson ... two specific histone modifications in tumor cells of patients ...
Cached Biology News:2 years old -- a childhood obesity tipping point? 2Engineer studies tensional integrity of biological structures 2Engineer studies tensional integrity of biological structures 3Predicting prognosis and treatment response in a subset of pancreatic cancer patients 2Predicting prognosis and treatment response in a subset of pancreatic cancer patients 3